Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Moderna: Covid-19 Vaccine- Sooner than we think?

RC-PCR technology in SARS-Cov-2: Mega-Analyzer for outbreaks

Govt RGCB JRF & SRF Life Science Recruitment | Applications Invited

Moderna: Covid-19 Vaccine- Sooner than we think?
  • BiotechToday
  • India

Moderna: Covid-19 Vaccine- Sooner than we think?

bioxone November 1, 2020November 1, 2020

Avipsha Datta, Department of Biophysics and Molecular Biology, University of Calcutta

Covid-19 Vaccine- the one thing we are very much hoping for right now! Well, here is some news update that might give us a little more hope. The Drugmaker Company Moderna has announced that it is preparing to launch its potential Coronavirus vaccine mRNA-1273.Meanwhile, Johnson and Johnson is planning to start testing it’s experiment Covid-19 vaccine among those aged 12 to 18.

 Moderna CEO Stephanie Bancel has said in a press conference in recent times that they are actively preparing to launch its potential Coronavirus vaccine soon. They have signed a number of supply agreements with the governments around the globe.

According to the reports, the company has received $1.1 billion in customer deposits for the shots during the third quarter. Last week, Moderna has completed enrollment for the 30,000 Stage-3 Clinical trials. Till then, more than 25,650 volunteers have received the second of the company’s two-dose Covid-19 vaccine. Most of the participants were from diverse communities and 42% were at a high risk of severe diseases.

Moderna has further stated that it would seek emergency FDA authorization to use vaccine high-risk groups if an interim assessment of its trail showed that the vaccine was at least 70% effective. Moderna is hopeful that we might have an approved Covid-19 vaccine by the end of this year.

Also read: EFFECT OF MISSENSE VARIATIONs: REVELEALED

References: https://www.indiatoday.in/coronavirus-outbreak/story/coronavirus-vaccine-news-moderna-preparing-to-launch-potential-vaccine-johnson-johnson-conduct-tests-youth-teens-1736752-2020-10-31

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged coronavirus india COVID INDIA COVID NEWS COVID update covid vaccine india Covid-19 vaccine Covid-19 vaccine trials Covid-19 vaccine updates Johnson and Johnson moderna moderna vaccine mRNA vaccine phase 3 trials vaccine by end of 2020

One thought on “Moderna: Covid-19 Vaccine- Sooner than we think?”

  1. Pingback: Multisystem inflammatory syndrome associated with SARS-CoV-2 - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Govt RGCB JRF & SRF Life Science Recruitment | Applications Invited

bioxone November 1, 2020

-Shristi Sharma, Team bioXone Govt RGCB JRF & SRF Life Science Recruitment – Applications Invited. RGCB, Thiruvananthapuram is hiring MSc/MTech Life Science candidates. Life Science Job Opening. Interested and eligible candidates can check out all of the details below: Adv. # 12/2020 POST I NAME OF THE POST: Junior Research Fellow NO. OF POSTS: 01 […]

Related Post

  • BiotechToday
  • India
  • World

Vamorolone- A new hope in Duchenne muscular dystrophy

bioxone September 28, 2020September 28, 2020

Aakancha Shaw, St. Xavier’s College (Kolkata) Muscular dystrophy implies a group of inherited disorders that can cause loss of muscle tissue, muscle weakness and delayed development. which gets worse over time. Duchenne muscular dystrophy is such muscular dystrophy that worsens quickly unlike the other types of muscular dystrophy. DMD refers to the genetic disorder wherein […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Magnetosomes- The New Age Bacterial Magnetic Nanoparticles

bioxone February 22, 2021February 22, 2021

Shrayana Ghosh, Amity University Kolkata In biomedicine and biotechnology, the biosynthesis of magnetic nanoparticles using bacteria could soon play an important role. A process for the isolation and purification of these particles from bacterial cells has now been developed and optimized by researchers from the University of Bayreuth. Magnetosomes exhibited good biocompatibility in initial testing […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Mantis- A high-quality protein function annotation tool

bioxone November 6, 2020November 5, 2020

Prama Ghosh, Amity University Kolkata There has been a rapid development in the field of meta-omics in the past decade thereby producing an unprecedented amount of data. Methods such as Next Generation Sequencing produce a large amount of data that needs to be interpreted to understand the role of previously functionally unannotated proteins of an […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy